BTIG Initiates Coverage On P3 Health Partners with Buy Rating, Announces Price Target of $5
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst David Larsen has initiated coverage on P3 Health Partners (NASDAQ:PIII) with a Buy rating and a price target of $5.
September 01, 2023 | 8:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
P3 Health Partners has been initiated with a Buy rating by BTIG, with a price target of $5.
The initiation of coverage by BTIG with a Buy rating indicates a positive outlook for P3 Health Partners. The price target of $5 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100